220 related articles for article (PubMed ID: 3350995)
21. Relationship between vitamin K1 2,3-epoxide and vitamin K1 in patients treated with N-methyl-thiotetrazole cephalosporins.
Schäfer H; Matthias FR
Thromb Res; 1992 Feb; 65(3):439-42. PubMed ID: 1631806
[No Abstract] [Full Text] [Related]
22. Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers.
von Kries R; Shearer MJ; Widdershoven J; Motohara K; Umbach G; Göbel U
Thromb Haemost; 1992 Oct; 68(4):383-7. PubMed ID: 1448768
[TBL] [Abstract][Full Text] [Related]
23. Plasma concentrations of vitamin K1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birth.
Widdershoven J; Lambert W; Motohara K; Monnens L; de Leenheer A; Matsuda I; Endo F
Eur J Pediatr; 1988 Nov; 148(2):139-42. PubMed ID: 3234435
[TBL] [Abstract][Full Text] [Related]
24. Hypoprothrombinemia associated with cefoperazone therapy.
Mueller RJ; Green D; Phair JP
South Med J; 1987 Nov; 80(11):1360-2. PubMed ID: 3686136
[TBL] [Abstract][Full Text] [Related]
25. Vitamin K-reversible hypoprothrombinemia in rats. I. Sex differences in the development of hypoprothrombinemia and the effects of beta-lactam antibiotics.
Matsuura M; Satoh S; Takano K; Harauchi T; Yoshizaki T; Kobayashi F; Matsubara T; Uchida K
Jpn J Pharmacol; 1988 Mar; 46(3):303-10. PubMed ID: 3379837
[TBL] [Abstract][Full Text] [Related]
26. Effect of flomoxef on blood coagulation and alcohol metabolism.
Uchida K; Matsubara T
Infection; 1991; 19 Suppl 5():S284-95. PubMed ID: 1783445
[TBL] [Abstract][Full Text] [Related]
27. Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants.
Cornelissen EA; Kollée LA; De Abreu RA; van Baal JM; Motohara K; Verbruggen B; Monnens LA
Arch Dis Child; 1992 Oct; 67(10):1250-4. PubMed ID: 1444522
[TBL] [Abstract][Full Text] [Related]
28. Cephalosporin-induced alteration in hepatic glutathione redox state. A potential mechanism for inhibition of hepatic reduction of vitamin K1,2,3-epoxide in the rat.
Mitchell MC; Mallat A; Lipsky JJ
J Clin Invest; 1990 Nov; 86(5):1589-94. PubMed ID: 1978724
[TBL] [Abstract][Full Text] [Related]
29. Bioavailability of phylloquinone from an intravenous lipid emulsion.
Camilo ME; Jatoi A; O'Brien M; Davidson K; Sokoll L; Sadowski JA; Mason JB
Am J Clin Nutr; 1998 Apr; 67(4):716-21. PubMed ID: 9537619
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic-induced vitamin K deficiency and the role of the presence of intestinal flora.
Shirakawa H; Komai M; Kimura S
Int J Vitam Nutr Res; 1990; 60(3):245-51. PubMed ID: 2276882
[TBL] [Abstract][Full Text] [Related]
31. Studies on oxacephem antibiotics: comparison of the effects of 1-oxa and 1-thia cephalosporins on blood coagulation activities and vitamin K metabolism in rats.
Uchida K; Matsubara T; Hirauchi K
Jpn J Pharmacol; 1989 Jul; 50(3):283-8. PubMed ID: 2761130
[TBL] [Abstract][Full Text] [Related]
32. Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
Shimada K; Matsuda T; Inamatsu T; Urayama K
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():325-30. PubMed ID: 6389475
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 1966-1988.
Shevchuk YM; Conly JM
Rev Infect Dis; 1990; 12(6):1109-26. PubMed ID: 2267487
[TBL] [Abstract][Full Text] [Related]
34. A study of factors which determine the pharmacological response to vitamin K in coumarin anticoagulated rabbits.
Hart JA; Haynes BP; Park BK
Biochem Pharmacol; 1984 Oct; 33(19):3013-9. PubMed ID: 6487353
[TBL] [Abstract][Full Text] [Related]
35. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan.
Kaiser CW; McAuliffe JD; Barth RJ; Lynch JA
Arch Surg; 1991 Apr; 126(4):524-5. PubMed ID: 1901205
[TBL] [Abstract][Full Text] [Related]
36. The effects of salicylate on enzymes of vitamin K metabolism.
Hildebrandt EF; Suttie JW
J Pharm Pharmacol; 1983 Jul; 35(7):421-6. PubMed ID: 6136582
[TBL] [Abstract][Full Text] [Related]
37. Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.
Welage LS; Hejmanowski LG; Wilton JH; Walawander C; Rigan D; Williams JS; Schentag JJ
Antimicrob Agents Chemother; 1989 Jun; 33(6):857-61. PubMed ID: 2764537
[TBL] [Abstract][Full Text] [Related]
38. Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1.
Fetrow CW; Overlock T; Leff L
J Clin Pharmacol; 1997 Aug; 37(8):751-7. PubMed ID: 9378848
[TBL] [Abstract][Full Text] [Related]
39. Vitamin K metabolism in a patient resistant to vitamin K antagonists.
Keréveur A; Leclercq M; Trossaërt M; Dupeyron JP; Parent F; Horellou MH; Conard J; Bachmann F; Samama MM
Haemostasis; 1997; 27(4):168-73. PubMed ID: 9483171
[TBL] [Abstract][Full Text] [Related]
40. Hemostasis in patients with normal and impaired renal function under treatment with cefodizime.
Andrassy K; Koderisch J; Trenk D; Jähnchen E; Iwand A
Infection; 1987; 15(5):348-50. PubMed ID: 3692605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
